In the BioHarmony Drug Report Database

"Preview" Icon

Menthol

Salonpas (menthol) is a small molecule pharmaceutical. Menthol was first approved as Salonpas on 2008-02-20. It is used to treat pain and skin diseases in the USA. The pharmaceutical is active against transient receptor potential cation channel subfamily M member 8, alpha-1A adrenergic receptor, and alpha-2A adrenergic receptor. In addition, it is known to target transient receptor potential cation channel subfamily A member 1, transient receptor potential cation channel subfamily M member 8, transient receptor potential cation channel subfamily V member 3, alpha-2B adrenergic receptor, 5-hydroxytryptamine receptor 1B, 5-hydroxytryptamine receptor 1D, alpha-1B adrenergic receptor, 5-hydroxytryptamine receptor 2C, alpha-2C adrenergic receptor, and alpha-1D adrenergic receptor. Med aid chest rub’s patent is valid until 2030-01-03 (FDA).

 

Trade Name

 

Salonpas
 

Common Name

 

menthol
 

ChEMBL ID

 

CHEMBL256087
 

Indication

 

pain, skin diseases
 

Drug Class

 

Image (chem structure or protein)

Menthol structure rendering